175 related articles for article (PubMed ID: 11908694)
21. Vascular endothelial growth factor and platelet-derived endothelial cell growth factor expression are implicated in the angiogenesis of endometrial cancer.
Seki N; Kodama J; Hongo A; Miyagi Y; Yoshinouchi M; Kudo T
Eur J Cancer; 2000 Jan; 36(1):68-73. PubMed ID: 10741297
[TBL] [Abstract][Full Text] [Related]
22. The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter.
Inoue K; Kamada M; Slaton JW; Fukata S; Yoshikawa C; Tamboli P; Dinney CP; Shuin T
Clin Cancer Res; 2002 Jun; 8(6):1863-70. PubMed ID: 12060629
[TBL] [Abstract][Full Text] [Related]
23. [Expression of VEGF, bFGF and ER in endometrial carcinoma].
Bai X; Mi R
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):211-3. PubMed ID: 11783088
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
25. Neoangiogenesis in patients with gastric carcinoma in relation to the expression of vascular endothelial growth factor and thymidine phosphorylase.
Tsujitani S; Saito H; Maeta Y; Yamaguchi K; Tatebe S; Kondo A; Kaibara N
Anticancer Res; 2004; 24(3b):1853-9. PubMed ID: 15274366
[TBL] [Abstract][Full Text] [Related]
26. Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma.
Yokoyama Y; Charnock-Jones DS; Licence D; Yanaihara A; Hastings JM; Holland CM; Emoto M; Sakamoto A; Sakamoto T; Maruyama H; Sato S; Mizunuma H; Smith SK
Clin Cancer Res; 2003 Apr; 9(4):1361-9. PubMed ID: 12684405
[TBL] [Abstract][Full Text] [Related]
27. The correlation between immunohistochemically-detected markers of angiogenesis and serum vascular endothelial growth factor in patients with breast cancer.
Lantzsch T; Hefler L; Krause U; Kehl A; Goepel C; Koelbl H; Dunst J; Lampe D
Anticancer Res; 2002; 22(3):1925-8. PubMed ID: 12168895
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic study of neovascularization and VEGF expression in superficial esophageal carcinoma.
Fujii T; Sudo T; Sueyoshi S; Tanaka T; Fujita H; Shirouzu K; Ban S; Toyonaga A; Kato S; Yamana H
Int J Oncol; 2002 Dec; 21(6):1181-7. PubMed ID: 12429966
[TBL] [Abstract][Full Text] [Related]
29. Angiogenesis in gastric cancer: importance of the thymidine phosphorylase expression of cancer cells as an angiogenic factor.
Han HS; Hwang TS
Oncol Rep; 2007 Jan; 17(1):61-5. PubMed ID: 17143479
[TBL] [Abstract][Full Text] [Related]
30. The angiogenic switch of human colon cancer occurs simultaneous to initiation of invasion.
Takahashi Y; Ellis LM; Mai M
Oncol Rep; 2003; 10(1):9-13. PubMed ID: 12469136
[TBL] [Abstract][Full Text] [Related]
31. Activated VEGFR2/KDR pathway in tumour cells and tumour associated vessels of colorectal cancer.
Giatromanolaki A; Koukourakis MI; Sivridis E; Chlouverakis G; Vourvouhaki E; Turley H; Harris AL; Gatter KC
Eur J Clin Invest; 2007 Nov; 37(11):878-86. PubMed ID: 17883421
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A
Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical expression of thymidine phosphorylase in human endometrial cancer.
Fujiwaki R; Hata K; Iida K; Koike M; Miyazaki K
Gynecol Oncol; 1998 Mar; 68(3):247-52. PubMed ID: 9570975
[TBL] [Abstract][Full Text] [Related]
34. Angiogenesis in benign, pre-malignant and malignant vulvar lesions.
Bamberger ES; Perrett CW
Anticancer Res; 2002; 22(6C):3853-65. PubMed ID: 12553005
[TBL] [Abstract][Full Text] [Related]
35. Plausible linkage of hypoxia-inducible factor (HIF) in uterine endometrial cancers.
Fujimoto J; Sato E; Alam SM; Jahan I; Toyoki H; Hong BL; Sakaguchi H; Tamaya T
Oncology; 2006; 71(1-2):95-101. PubMed ID: 17341889
[TBL] [Abstract][Full Text] [Related]
36. VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-VEGF antibodies in experimental tumors.
Zielke A; Middeke M; Hoffmann S; Colombo-Benkmann M; Barth P; Hassan I; Wunderlich A; Hofbauer LC; Duh QY
Surgery; 2002 Dec; 132(6):1056-63; discussion 1063. PubMed ID: 12490855
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of angiogenesis, p-53 tissue protein expression and serum VEGF in patients with endometrial cancer.
Mazurek A; Pierzyński P; Kuć P; Kopinski P; Terlikowski S; Niklińska W; Trojan J; Laudański T
Neoplasma; 2004; 51(3):193-7. PubMed ID: 15254672
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of estrogen receptor-alpha in the endometrial carcinoma cell line Ishikawa: inhibition of growth and angiogenic factors.
Ali SH; O'Donnell AL; Mohamed S; Mousa S; Dandona P
Gynecol Oncol; 2004 Dec; 95(3):637-45. PubMed ID: 15581976
[TBL] [Abstract][Full Text] [Related]
39. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
[TBL] [Abstract][Full Text] [Related]
40. Thymidine phosphorylase expression in endometrial carcinomas.
Sivridis E; Giatromanolaki A; Koukourakis MI; Bicknell R; Harris AL; Gatter KC
Clin Exp Metastasis; 1999 Jul; 17(5):445-50. PubMed ID: 10651312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
